Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
BCAL Diagnostics Limited ( (AU:BDX) ) has shared an announcement.
BCAL Diagnostics Limited has announced its Annual General Meeting (AGM) for shareholders, scheduled for 28 November 2025 in Sydney, with an option for online attendance. Shareholders are encouraged to submit proxy forms and questions in advance, as online attendees will not be able to vote during the meeting. This meeting is crucial for stakeholders to engage with the company’s strategic direction and governance.
More about BCAL Diagnostics Limited
BCAL Diagnostics Limited operates in the healthcare industry, focusing on diagnostic solutions. The company provides innovative diagnostic services and products, with a market focus on improving healthcare outcomes through advanced diagnostic technologies.
Average Trading Volume: 382,592
Technical Sentiment Signal: Buy
Current Market Cap: A$32.94M
See more data about BDX stock on TipRanks’ Stock Analysis page.